Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total Stockholders’ Equity
Balance at Sep. 30, 2020		$ 23,049	$ 141,057	$ (1,558,313)		$ (1,394,207)
Balance (in Shares) at Sep. 30, 2020		230,485,100
Net income (Loss)				(53,595)		(53,595)
Balance at Dec. 31, 2020		$ 23,049	141,057	(1,611,908)		(1,447,802)
Balance (in Shares) at Dec. 31, 2020		230,485,100
Net income (Loss)				49		49
Balance at Mar. 31, 2021		$ 23,049	141,057	(1,611,859)		(1,447,753)
Balance (in Shares) at Mar. 31, 2021		230,485,100
Balance at Sep. 30, 2021		$ 33,203	14,474,839	(2,495,159)	$ 8,440	12,021,323
Balance (in Shares) at Sep. 30, 2021		332,024,371
Adjustment for asset acquisition			(2,861,631)			(2,861,631)
Common stock issued in connection with cost method investment		$ 2,000	6,600,000			6,602,000
Common stock issued in connection with cost method investment (in Shares)		20,000,000
Stock-based compensation			378,746			378,746
Net income (Loss)				(1,944,839)		(1,944,839)
Foreign currency translation adjustment					(2,227)	(2,227)
Balance at Dec. 31, 2021		$ 35,203	18,591,954	(4,439,998)	6,213	14,193,372
Balance (in Shares) at Dec. 31, 2021		352,024,371
Common stock issued in connection with cost method investment		$ 1,515	4,998,485			5,000,000
Common stock issued in connection with cost method investment (in Shares)		15,151,515
Stock options issued for the purchase of an intangible asset			11,237			11,237
Stock-based compensation			525,622			525,622
Net income (Loss)				(1,926,614)		(1,926,614)
Foreign currency translation adjustment					13,214	13,214
Balance at Mar. 31, 2022		$ 36,718	$ 24,127,298	$ (6,366,612)	$ 19,427	$ 17,816,831
Balance (in Shares) at Mar. 31, 2022		367,175,886